-
EP1392359
European procedure
Extract from the Register of European Patents
EP Citations: EP1392359
| Cited in | Search | Type: | Non-patent literature | Publication information: | [A] - FERNANDES H ET AL, "Glycosylation-induced conformational modification positively regulates receptor-receptor association: a study with an aberrant epidermal growth factor receptor (EGFRvIII/DeltaEGFR) expressed in cancer cells.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 16 FEB 2001, (20010216), vol. 276, no. 7, ISSN 0021-9258, pages 5375 - 5383, XP002343750 [A] 1-43 * the whole document * | DOI: | http://dx.doi.org/10.1074/jbc.M005599200 | Type: | Non-patent literature | Publication information: | [A] - KUAN C T ET AL, "Increased binding affinity enhances targeting of glioma xenografts by EGFRvIII-specific scFv.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER. 15 DEC 2000, (20001215), vol. 88, no. 6, ISSN 0020-7136, pages 962 - 969, XP001024149 [A] 1-43 * the whole document * | DOI: | http://dx.doi.org/10.1002/1097-0215(20001215)88:6<962::AID-IJC20>3.0.CO;2-U | Type: | Non-patent literature | Publication information: | [PX] - LUWOR R B ET AL, "Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR.", CANCER RESEARCH. 15 JUL 2001, (20010715), vol. 61, no. 14, ISSN 0008-5472, pages 5355 - 5361, XP002343751 [PX] 1-43 * the whole document * | Type: | Non-patent literature | Publication information: | [PX] - JOHNS TERRANCE G ET AL, "Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.", INTERNATIONAL JOURNAL OF CANCER. JOURNAL INTERNATIONAL DU CANCER. 20 MAR 2002, (20020320), vol. 98, no. 3, ISSN 0020-7136, pages 398 - 408, XP002343752 [PX] 1-43 * the whole document * | DOI: | http://dx.doi.org/10.1002/ijc.10189 | Cited in | International search | Type: | Patent literature | Publication No.: | US5401828
[X] (VOGELSTEIN BERT [US], et al); | Type: | Patent literature | Publication No.: | US5795965
[X] (TSUCHIYA MASAYUKI [JP], et al) | Cited in | Examination | Type: | Non-patent literature | Publication information: | - MISHIMA ET AL, "Growth suppression of intracranial xenografted glioblastomas overexpressing mutant epidermal growth factor receptors by systemic administration of monoclonal antibody (mAb) 806, a novel monoclonal antibody directed to the receptor", CANCER RESEARCH, (20010715), vol. 61, no. 14, pages 5349 - 5354, XP008071639 | Type: | Non-patent literature | Publication information: | - SIVASUBRAMANIAN A. ET AL, "Structural model of the mAb 806-EGFR complex using computational docking followed by computational and experimental mutagenesis", STRUCTURE, (200603), vol. 14, no. 3, pages 401 - 414, XP000533233 | DOI: | http://dx.doi.org/10.1088/0957-0233/6/6/001 | Type: | Non-patent literature | Publication information: | - JOHNS T. ET AL, "Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor", JOURNAL OF BIOLOGICAL CHEMISTRY, (20040716), vol. 279, no. 29, pages 30375 - 30384, XP008071652 | DOI: | http://dx.doi.org/10.1074/jbc.M401218200 | Type: | Non-patent literature | Publication information: | - JOHNS T. ET AL, "The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor", FASEB JOURNAL, (2005), vol. 19, no. 7, pages 780 - 782, XP008071641 | DOI: | http://dx.doi.org/10.1096/fj.04-2370com | Type: | Non-patent literature | Publication information: | - MARKS J.D. ET AL, "By-passing immunization: Building high affinity human antibodies by chain shuffling", BIO/TECHNOLOGY, (199207), vol. 10, no. 7, pages 779 - 793, XP002917376 | DOI: | http://dx.doi.org/10.1038/nbt0792-779 | Cited in | by applicant | Type: | Patent literature | Publication No.: | US4341761
| Type: | Patent literature | Publication No.: | US4342566
| Type: | Patent literature | Publication No.: | US4399121
| Type: | Patent literature | Publication No.: | US4427783
| Type: | Patent literature | Publication No.: | US4444887
| Type: | Patent literature | Publication No.: | US4451570
| Type: | Patent literature | Publication No.: | US4466917
| Type: | Patent literature | Publication No.: | US4472500
| Type: | Patent literature | Publication No.: | US4491632
| Type: | Patent literature | Publication No.: | US4493890
| Type: | Non-patent literature | Publication information: | - MILAS, CLIN CANCER RES., (200002), vol. G, no. 2, page 701 8 | Type: | Non-patent literature | Publication information: | - HUANG ET AL., CLIN CANCER RES., (200006), vol. 6, no. 6, pages 2166 - 74 | Type: | Non-patent literature | Publication information: | - RAFF, M.E., CURR. OPINION BIOTECH., (1993), vol. 4, pages 573 - 576 | Type: | Non-patent literature | Publication information: | - TRILL J.J. ET AL., CURR. OPINION BIOTECH, (1995), vol. 6, pages 553 - 560 | Type: | Non-patent literature | Publication information: | - DENARDO SJ; KROGER LA; DENARDO GL, "A new era for radiolabeled antibodies in cancer?", CURR OPIN IMMUNOL, (1999), vol. 11, pages 563 - 9 |